Current location:style >>
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
style1People have gathered around
IntroductionWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the b ...
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Global Grid news portal”。http://tunisia.brianlynch.org/article-62b399629.html
Related articles
Lafrenière continuing his breakthrough season as a solid contributor for Rangers in NHL playoffs
styleAfter a breakthrough regular season, Alexis Lafrenière has continued to be a solid contributor for t ...
【style】
Read moreTaylor Swift fans believe they have decoded the singer's 'bronze spray
styleTaylor Swift fans believe they have uncovered the 'bronze spray-tanned statue' line referenced in he ...
【style】
Read moreFlorida sues ACC seeking records in dispute with FSU over conference exit fees
styleTALLAHASSEE, Fla. (AP) — Florida’s attorney general sued the Atlantic Coast Conference on Thursday i ...
【style】
Read more
Popular articles
- Trump or Biden? Either way, US seems poised to preserve heavy tariffs on imports
- Planned Parenthood announces $10 million voter campaign in North Carolina for 2024 election
- Here are 14 players to watch next season across the Atlantic Coast Conference
- The TikTok law kicks off a new showdown between Beijing and Washington. What's coming next?
- Minnesota Equal Rights Amendment fails in acrimonious end to legislative session
- Kentucky coach Mark Pope adds Baylor assistant Alvin Brooks III as associate head coach
Latest articles
Kylie Jenner displays her VERY edgy fashion sense in cleavage
Federal judge temporarily blocks confusing Montana voter registration law
ABBA film chronicling the Swedish band's rise to global stardom includes never
Paris Hilton flashes her toned midriff and bronzed legs in a racy pink cut
Philippines blames China for loss of giant clams in disputed shoal and urges environmental inquiry
Martine McCutcheon admits she's 'feeling c***py' as she shares her health diagnosis with fans
LINKS
- 4th China Cross
- Sydney mall stabbing: Officer, bystanders hailed for confronting and stopping attacker
- Textile enterprises in Zhejiang advance green, high
- China's Bluetooth headphone market grows in 2023
- China’s unemployment rate for youth aged 16
- China ready to unleash growth potential
- China trade fair Indonesia kicks off in Jakarta
- The astonishing effect of stem cell implants
- China's growth spurs optimism
- China sees over 7.2 bln inter